Items Tagged ‘General’

May 24, 2018

FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

By

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. While Lucemyra may lessen the severity of withdrawal symptoms, it may […]

View full entry

Tags: General, lofexidine hydrochloride, Lucemyra, News, opiod addiction, Opiod withdrawl, Other News Topics (not Types of Cancer)


May 21, 2018

FDA Approves Aimovig, A Novel Preventive Treatment for Migraine Headaches

By

According to Dr. Jessica Ailani, MD, associate professor of neurology at MedStar’s Georgetown University Hospital and director of the MedStar Georgetown Headache Center, migraines affect over 36 million people in the U.S. yet they are still a poorly recognized and under-diagnosed disease. In 2018, the number of migraine-specific treatments available in the US will double […]

View full entry

Tags: Aimovig, General, Headaches, Migraine, News, prevention, treatment


May 9, 2018

What is a Venous Access Device and What Types are Used for Cancer Patients?

By

A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. A VAD can be useful for patients undergoing systemic treatment with precision cancer medicines or chemotherapy because it allows for a single access that can be used repeatedly to draw blood and deliver medications thus avoiding frequent […]

View full entry

Tags: General, News


May 3, 2018

Lutathera Pepetide Receptor Radionuclide Therapy for NETs

By

CancerConnect News: Lutathera (lutetium Lu 177 dotatate) was recently approved for the treatment of neuroendocrine tumors (NETs) that typically occur in the pancreas and gastrointestinal tract. This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of NETs. PRRT and NET NET is an abbreviation for Neuro-Endocrine Tumor. These […]

View full entry

Tags: General, News, Other News Topics (not Types of Cancer)


March 21, 2018

CancerConnect – Online Support & Networking for Cancer Patients

By

Social networking sites are rapidly growing, giving patients with cancer a place to connect with others. On line social groups on Facebook, discussion boards, and peer to peer networking connections have become widely available and serve some specific needs unique to cancer patients and their caregivers. In fact many leading cancer centers now offer social […]

View full entry

Tags: General, News


March 1, 2018

Managing a rare cancer

By

Managing a rare cancer diagnosis presents unique challenges. One survivor shares her tips for navigating the sometimes-murky waters. CancerConnect News: Happy New Year: January 7  (the day I became really special). On January 7, I became really special. The pathologist at Good Samaritan Medical Center in West Palm Beach, Florida, where I had been hospitalized […]

View full entry

Tags: General, genomics, News, Precision Cancer Medicine, rare cancers


February 6, 2018

FDA Approves Lutathera for Treatment for Certain Digestive Tract Cancers

By

CancerConnect News: The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This is the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of GEP-NETs. Lutathera is […]

View full entry

Tags: General, News


January 8, 2018

Cancer Patients are Relatively Unaware of the Role of Precision Cancer Medicine, Genomics and Biomarker Testing

By

CancerConnect News: Precision cancer medicines and the companion tests used to identify them are increasingly important in the management of cancer.  It is important to understand how aware patients are of these evolving treatment options and whether they are being discussed with their doctors. Our recent survey suggests that only one third of cancer patients […]

View full entry

Tags: Biomarkers, cancer connect, General, genomics, News, Precision Cancer Medicine, targeted therapy


December 14, 2017

What to Tell Children when Facing a Diagnosis of Cancer

By

If you have children in your life, you already know that they tend to be creatures of habit who rely on their daily routine. There may be unexpected changes in their routine with your fight against cancer, and you may be concerned about the best way to talk to them about it. Whether you’re a […]

View full entry

Tags: cancer, children, General, News


December 7, 2017

FDA and CMS Collaborate to Make Novel Cancer Biomarker Test Available

By

The U.S. Food and Drug Administration (FDA) has approved the F1CDx biomarker test designed to detect mutations in 324 genes and two genomic signatures in cancer patients. In a truly collaborative effort between the FDA and The Centers for Medicare & Medicaid Services (CMS) the latter proposed coverage of the F1CDx test under the new […]

View full entry

Tags: biomarker testing, CMS, foundation medicine, General, genomic testing, immunotherapy, KEYNOTE-028, News, Other News Topics (not Types of Cancer), PD-L1 positive, Precision Cancer Medicine, SCLS


December 1, 2017

Understanding Low Back Pain

By

From theSpineCommunity Back pain is a symptom associated with over 60 different medical conditions.  These disorders involve a number of different organ systems.  A variety of healthcare professionals have expertise that can be useful in the diagnosis and treatment of these illnesses.  The following list contains a list of some of those professionals who can […]

View full entry

Tags: General, Health and Wellness, News


October 19, 2017

Flu Shot 101 – What You Need to Know

By

Flu season is here again, and besides a fever and runny nose, it can bring about the longtime controversy surrounding vaccines. In order to protect more human lives this year and to clarify some of the most common misconceptions surrounding the flu vaccine, the team at ConsumerSafety.org met with Dr. William Schaffner, an infectious disease […]

View full entry

Tags: flu vaccine, General, Influenza, News


September 8, 2017

CancerConnect On Line Support Community Available for Cancer Patients and Caregivers Impacted by Hurricane Irma

By

CancerConnect is a specialized social network for patients with cancer and their caregivers. All the members of the CancerConnect community are hoping for the best for everyone in Florida facing the coming wrath of Hurricane Irma. We are especially concerned for post surgical individuals and those undergoing chemotherapy and want to available for anyone with […]

View full entry

Tags: Cancer Patient Support, Cancer Patients, CancerConnect, Florida, Florida Cancer Centers, Florida Cancer Clinics, Florida Cancer Hospitals, General, Hurricane Irma, News


September 7, 2017

Liquid Biopsies Find Distinct Genomic Profiles in Most Patients with Carcinoma of Unknown Primary

By

New research suggests that a simple blood test to evaluate circulating tumor DNA (ctDNA) can correctly identify distinct genomic profiles with potentially treatable targetable alterations in patients with carcinoma of unknown primary (CUP).1 Identifying the origin of cancers historically referred to as a cancer of unknown primary it has been problematic to determine how to […]

View full entry

Tags: Carcinoma of Unknown Primary, circulating tumor DNA, General, Genomic Profile, Liquid Biopsy, News, Precision Cancer Medicine


August 19, 2015

Smoking Cessation Drug Not Boosting Number of Smokers Who Quit

By

The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest […]

View full entry

Tags: cessation aides, Chantix, General, Other News Topics (not Types of Cancer), quit smoking, tobacco control, varenicline